SCIASCIA THOMAS - Insider Non-Derivative Transactions at Trevi Therapeutics, Inc. (TRVI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 19, 2024, SCIASCIA THOMAS's relationship to Trevi Therapeutics, Inc. (TRVI) is Officer (Chief Scientific Officer), and currently has 236,811 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TRVI insiders.

Data Source: SEC.
SCIASCIA THOMAS - Insider Non-Derivative Transactions of TRVI Common Stock
SCIASCIA THOMAS - Insider Non-Derivative Transactions at TRVI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 20, 2024 Sell -- (Common Stock) 16496 2.96 220315
Aug 20, 2024 M -- (Common Stock) 16496 1.43 236811
Aug 17, 2024 Sell -- (Common Stock) 18660 2.76 220315
Aug 17, 2024 M -- (Common Stock) 18660 1.43 238975
Aug 16, 2024 Sell -- (Common Stock) 12745 2.79 220315
Aug 16, 2024 M -- (Common Stock) 12745 1.43 233060
Aug 15, 2024 Sell -- (Common Stock) 100 2.75 220315
Aug 15, 2024 M -- (Common Stock) 100 1.43 220415
May 30, 2024 Sell -- (Common Stock) 53368 2.55 214433
May 30, 2024 M -- (Common Stock) 59354 2.19 267801